BY ALBERT RONNING-ANDERSSON
-
Bristol Myers Squibb fails in phase 3 trial of schizophrenia drug
The stage 3 test checked the medication Cobenfy in individuals with schizophrenia that no more react to their existing antipsychotic therapies.
-
SSI Diagnostica increases US footprint with another acquisition
With the procurement of Gulf Coastline Scientific, the diagnostics business acquires 30 brand-new staff members, that in 2024 added to the United States business’s income of …
-
WS Audiology expands footprint in India with new production facilities
that’s info programs that an approximated 6.3% of India’s populace struggles with substantial hearing loss.
-
New capital injection reduces WSA’s towering debt
CFO claims the resources rise must not be seen straight as component of a forthcoming IPO, however it is still among the opportunities.
-
New capital injection reduces WSA’s towering debt
CFO says the capital increase should not be seen directly as part of an upcoming IPO, but it is still one of the possibilities.
-
AGC Biologics launches new cell and gene therapy unit
With the brand-new company system, the agreement producer intends to end up being favored companion in the area.
-
Roche Denmark appoints interim country manager
Till a long-term substitute for Darine Ghanem is discovered, Maria Falkenberg Petersen will certainly supervise of Roche Pharmaceuticals’ Danish service.
-
AGC Biologics launches new cell and gene therapy unit
With the new business unit, the contract manufacturer aims to become preferred partner in the field.
-
New production setup has worked: Supplier to the hearing aid industry achieves record results
Brand-new items and even more consumers are increasing both leading and profits for Estron, a producer of elements for listening to help and various other items. Geopolitical chaos…
-
AGC Biologics launches new cell and gene therapy unit
With the new business unit, the contract manufacturer aims to become preferred partner in the field.
